BioMaxima S.A.

Warsaw Stock Exchange BMX.WA

BioMaxima S.A. Interest Coverage Ratio for the year ending December 31, 2023: 1.31

BioMaxima S.A. Interest Coverage Ratio is 1.31 for the year ending December 31, 2023, a -98.29% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • BioMaxima S.A. Interest Coverage Ratio for the year ending December 31, 2022 was 76.51, a 17.38% change year over year.
  • BioMaxima S.A. Interest Coverage Ratio for the year ending December 31, 2021 was 65.19, a 104.20% change year over year.
  • BioMaxima S.A. Interest Coverage Ratio for the year ending December 31, 2020 was 31.92, a 2,337.55% change year over year.
  • BioMaxima S.A. Interest Coverage Ratio for the year ending December 31, 2019 was 1.31, a 312.20% change year over year.
Key data
Date Interest Coverage Ratio Debt to Equity Ratio Interest Expense To Sales Inventory Turnover Ratio
Market news
Loading...
SV Wall Street
Warsaw Stock Exchange: BMX.WA

BioMaxima S.A.

CEO Mr. Lukasz Urban
IPO Date July 21, 2010
Location Poland
Headquarters ul. VetterOw 5
Employees 115
Sector Consumers Staples
Industries
Description

BioMaxima S.A. manufactures and distributes reagents for in vitro diagnostics in Poland. Its primary products include diagnostic reagents and analyzers for clinical chemistry; rapid tests and readers for detecting infectious diseases, cancer markers, cardiac markers, and drugs of abuse; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and reagents; reagents and immunological analyzers of cardiac markers; glucometers for professional use; and analyzers for gasometric tests and critical blood parameters tests. The company also provides surfaces and air controls; antibiotics discs and MIC strips; and chromogenic, dehydrated, and prepared culture media; and additives and supplements for media. It supplies its products to approximately 2,000 laboratories in Poland, as well as exports in the international markets. BioMaxima S.A. was founded in 2002 and is based in Lublin, Poland.

Similar companies

SLV.WA

Selvita S.A.

USD 10.82

1.26%

SNT.WA

Synektik Spólka Akcyjna

USD 57.73

6.62%

CLN.WA

Celon Pharma S.A.

USD 5.97

1.29%

BMC.WA

Bumech S.A.

USD 2.36

-1.10%

KPL.WA

Kino Polska TV Spolka Akcyjna

USD 4.83

2.02%

StockViz Staff

February 6, 2025

Any question? Send us an email